4,944 research outputs found

    Migrant workers, collaborative research and spatial pressures : an interview with Meng Yue

    No full text
    In July last year I had the opportunity to interview Meng Yue, literary scholar and author of Shanghai and the Edges of Empire (2006). Meng Yue has been collaborating with Toronto-based architect and artist Adrian Blackwell for a number of years, with their students from literature and architecture undertaking highly interesting research on the peripheral zones of Beijing. Questions of peri-urban food production, land use, resource distribution and the multiplication of labour skills have framed these investigations. The interview below is extracted from a considerably longer discussion we had in Beijing during the late summer of 2007, half of which was lost to the faulty battery of an ipod (the rest remains to be transcribed from video…)

    The Carcinogenic Risk of Psoriasis and Its Treatments

    No full text
    研究背景癬是一種慢性疾病,目前尚未有根治的治療方式,病人需要終身接受治療。且病情嚴重的病人需要長期使用全身性的藥物或光照療法才能緩解病情。外有研究顯示未接受過乾癬全身性藥物或治療的乾癬病人罹癌的危險性略高於一般族群,雖然無法斷言是乾癬本身引起的,但乾癬病人長期使用這些已證實或被懷疑有致癌性的全身性藥物或治療,是否會加成致癌之危險性是個值得深入探討之課題。 究目的 研究不同疾病嚴重度之乾癬病人發生非黑色素瘤皮膚癌、淋巴癌及黑色素瘤的間接標準化發生率比。並利用Time-dependent Cox 迴歸模型探討乾癬治療型態與非黑色素瘤皮膚癌發生的相關性。究材料與方法 以全民健康保險100 萬人承保抽樣歸人資料庫西元1997年至2007年間住院醫療費用清單明細檔和門診處方及治療明細檔之診斷欄位ICD-9碼為696、696.0或696.1之乾癬診斷的病人定義為乾癬世代。進入世代後被診斷為非黑色素瘤皮膚癌、黑色素瘤或淋巴癌的乾癬病人,且申報資料中有與診斷相符的治療者,定義為非黑色素瘤皮膚癌、黑色素瘤或淋巴癌個案。並按照是否曾接受過全身性治療將病人分為嚴重型乾癬及輕微型乾癬。以2005年100萬人承保抽樣歸人檔作為參照族群,計算乾癬世代相較於參照族群之癌症間接標準化發生率比。 校正年齡、性別、察爾森合併症嚴重度指標及砷暴露後,以Time-dependent Cox 迴歸模型分析不同事件發生點之各種治療型態變項 (PUVA療法、紫外線B光光線治療、Methotrexate、Cyclosporin、Retinoids、Azathioprine及Tar )累積治療次數及劑量對發生非黑色素瘤皮膚癌的影響,並針對Retinoids累積治療劑量計算之時間點進行敏感度分析。果 本研究定義之乾癬世代病人7061位,嚴重型乾癬的病人共870位,輕微型乾癬治療的病人共6191位。 校正年齡及性別後,大於40歲族群之非黑色素瘤皮膚癌間接標準化發生率比為4.29 (95% CI 2.90-6.35)。輕微型乾癬的非黑色素瘤皮膚癌間接標準化發生率比為3.72 (95% CI 2.34-5.90)。嚴重型乾癬的非黑色素瘤皮膚癌間接標準化發生率比為7.08 (95% CI 3.38-14.85)。黑色素瘤間接標準化發生率比為3.75 (95% CI 0.94-14.99)。輕微型乾癬的黑色素瘤間接標準化發生率比為2.26 (95% CI 0.32-16.04)。嚴重型乾癬的黑色素瘤間接標準化發生率比為11.01 (95% CI 1.55-78.16)。大於20歲的淋巴癌間接標準化發生率比為2.30 (95% CI 1.15-4.60)。輕微型乾癬的淋巴癌間接標準化發生率比為1.75 (95% CI 0.73-4.20)。嚴重乾癬的淋巴癌間接標準化發生率比為4.85 (95% CI 1.56-15.04)。在探討各種治療型態變項對發生非黑色素瘤皮膚癌的影響的Time-dependent Cox 迴歸模型中,包含6737位新診斷的乾癬病人,出現22個非黑色素瘤皮膚癌的事件。除年齡愈大及曾有砷暴露會增加非黑色素細胞瘤皮膚癌發生的危險性外,Azathioprine之累積治療劑量會增加非黑色素細胞瘤皮膚癌發生的危險性 (Hazard ratio 1.34) 。其他治療型態的累積治療次數及劑量對於非黑色素瘤皮膚癌的發生皆不具統計上的顯著意義。論 輕微型乾癬病人罹患非黑色素瘤皮膚癌的危險性高於參照族群,暗示著乾癬疾病本身具有致癌性。病情嚴重的乾癬病人罹患非黑色素瘤皮膚癌、黑色素瘤及淋巴癌的發生率略高,則可能與乾癬疾病嚴重度或治療型態相關。 目前關於Azathioprine的非黑色素瘤皮膚癌致癌性的研究大都是報告在類風溼性關節炎、器官移植或發炎性大腸疾病的病人。尚未有以Azathioprine治療乾癬引起非黑色素瘤皮膚癌的大型研究。 PUVA療法在西方國家的文獻中有顯著的非黑色素瘤皮膚癌致癌性,但在亞洲國家的文獻中相對危險性卻不若歐美國家那麼高。本研究PUVA療法對非黑色素瘤皮膚癌致癌危險性不顯著,除了種族及膚色差異外,累積治療次數偏低應該也是一個重要因素。至於Methotrexate及Cyclosporin治療的非黑色素瘤皮膚癌致癌危險性不顯著,可能與追蹤時間不夠長有關。論 接受過乾癬全身性藥物或PUVA療法的乾癬病人罹患非黑色細胞瘤皮膚癌、黑色素瘤及淋巴癌的危險性均高於一般族群。未曾接受過全身性藥物或PUVA療法的乾癬病人罹患非黑色細胞瘤皮膚癌的危險性高於一般族群,因此乾癬疾病本身即具有致非黑色細胞瘤皮膚癌的危險性。醫師在規劃病人治療計畫時須謹慎衡量利弊得失。本研究已證實全身性藥物治療中azathioprine與乾癬病人發生非黑色細胞瘤皮膚癌有關,乾癬病人應謹慎使用並減少紫外線曝曬。Backgroundsoriasis is a kind of chronic diseases which cannot be cured at present. Patients may need lifelong treatment. Moreover, patients in serious conditions may require long-term use of systemic drugs or phototherapy to ease the condition. everal studies have shown that psoriasis patients who do not receive systemic treatment have slightly higher risks of getting cancer than the general population. Although psoriasis is not confirmed to lead to cancer, it is worthwhile to discuss the issue more deeply concerning whether using systemic treatment proved or suspected to be carcinogenic increases the risks of getting cancer for psoriasis patients.tudy Purposehe study was aimed at discovering the Indirect Standardized Incidence Ratio (SIR) of nonmelanoma skin cancer (NMSC), lymphoma and melanoma happening on patients with various disease severity of psoriasis. The study would also explore the relevance between different treatment types and the occurrence of NMSC by means of Time-dependent Cox regression mode. aterial and Methodhe cohort of psoriasis was defined based on the administrative claims data of a randomly sampled cohort (n = 1,000,000) of National Health Insurance beneficiaries in Taiwan with the diagnostic column of ICD-9 code being 696, 696.0 or 696.1. Cases of NMSC, melanoma or lymphoma were defined when patients were diagnosed with the above diseases after getting into the cohort and treated with compatible treatment. Psoriasis patients were then divided into two groups: severe or mild in accordance with the experience of receiving systemic treatment. We calculate SIR of cancer for each study group.fter adjusting the age, gender, Charlson comorbidity index and arsenic-exposure, Time-dependent Cox regression model was then applied to analyze variables of treatments such as PUVA therapy, UVB therapy, Methotrexate, Cyclosporin, Retinoids, Azathioprine and Tar to discover how the timing of different events and the accumulated times of treatment as well as the amount of doses affected NMSC. The study also conducted sensitivity analysis of the timing of the accumulated doses of Retinoids.esultshere were 7061 patients defined as the generation of psoriasis, among which 870 were severe psoriasis patients and 6191 mild were ones. fter adjusting age and gender, the SIR of NMSC was 4.29 (95% CI 2.90-6.35) while the SIR of mild psoriasis was 3.72 (95% CI 2.34-5.90) and 7.08 (95% CI 3.38-14.85) of the SIR of severe psoriasis. The SIR of melanoma was 3.75 (95% CI 0.94-14.99) while the SIR of mild psoriasis was 2.26 (95% CI 0.32-16.04) and 11.01 (95% CI 1.55-78.16) of the SIR of severe psoriasis. The SIR of lymphoma was 2.30 (95% CI 1.15-4.60) while the SIR of mild psoriasis was 1.75(95% CI 0.73-4.20) and 4.85 (95% CI 1.56-15.04) of the SIR of severe psoriasis.here were 6737 patients newly diagnosed with psoriasis, among which 22 cases were diagnosed with NMSC in the Time-dependent Cox regression model of discovering the effects of variables of treatments on the occurrence of NMSC. In addition to age and arsenic-exposure, the more the accumulated doses of Azathioprine were, the higher risks of the occurrence of NMSC would be. There was no statistical significance of how the accumulated times and doses of the other treatment affected the occurrence of NMSC.iscussionild psoriasis patients had higher risks of getting NMSC than the reference group which implied psoriasis itself was carcinogenic. The occurrence rate of NMSC, melanoma and lymphoma was slightly higher for severe psoriasis patients, which was possibly related to the severity of psoriasis or its treatments.tudies concerning the risks of getting NMSC with Azathioprine were mainly about patients with rheumatoid arthritis, organs transplantation or inflammatory bowel disease. There were still no large scale researches regarding NMSC caused by psoriasis treated with Azathioprine. UVA therapy was significantly carcinogenic in getting NMSC in the West literatures while its risks were comparatively lower in Asian studies. The risk of getting NMSC with PUVA therapy in our study is not significant. In addition to the difference of races and skin types, the accumulated times of treatment tend to being low may be also a critical factor. As for the treatment of NMSC with Methotrexate and Cyclosporin, the risks of getting cancer were not significant, which may be the result of insufficient tracing time.onclusionhe risks of getting NMSC, melanoma and lymphoma for severe psoriasis patients were higher than the reference group. The risks of getting NMSC for mild psoriasis patients were higher than the reference group. Therefore, psoriasis itself was carcinogenic of getting NMSC. The study had proved that the occurrence of NMSC was related to psoriasis patients’ using Azathioprine. Consequently, psoriasis patients should use the drugs cautiously and avoid being exposed to the ultra light.口試委員會審定書……………………………………………………… i謝…………………………………………………………………… ii文摘要……………………………………………………………… iii文摘要……………………………………………………………… vi錄…………………………………………………………………….ix目錄………………………………………………………………….xi目錄………………………………………………………………xiiii一章 緒論…………………………………………………… 1一節 研究背景………………………………………………… 1二節 研究目的.……………………………………………… 2 三節 研究重要性…………………………………………… 2二章 文獻回顧……………………………………………………3 一節 與乾癬相關之癌症型態的研究……………………………3 二節 乾癬治療型態與致癌性之相關研究………………………12 三節 治療型態可能之致癌機轉…………………………………26三章 研究架構………………………………………………… 28四章 研究的材料與方法………………………………………29一節 研究設計……………………………………………………29 二節 資料來源………………………………………………… 29 三節 研究對象……………………………………………………30 四節 資料處理流程………………………………………………31 五節 乾癬世代癌症間接標準化發生率比………………………32 六節 Time-dependent Cox 迴歸模型變項定義…………………34七節 資料處理與統計分析………………………………………39八節 研究假說……………………………………………………40五章 研究結果……………………………………………………41一節 乾癬世代基本特性描述 ………………………………41 二節 乾癬世代癌症標準化發生率……………………………41 三節 Time-dependent Cox 迴歸模型中新診斷的乾癬病人基本特性與治療型態描述…………………………………………………47四節 Time-dependent Cox 迴歸模型變項分析............52六章 討論與結論一節 研究結果討論……………………………………………62二節 研究的限制………………………………………………69三節 結論………………………………………………………70四節 未來研究的建議…………………………………………71考文獻………………………………………………………………7

    Correction to: Visible lattice points along curves

    No full text
    The article “Visible lattice points along curves”, written by Kui Liu and Xianchang Meng, was originally published electronically on the publisher’s internet portal on 27 July 2020 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 9 July 2021 to © The Author(s) 2020 and the article is forthwith distributed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0

    Sequels to honglou meng : how gu taiqing continues the story in honglou meng ying

    No full text
    After Honglou meng (1791) was published, a number of sequels appeared that redefined its major characters, rewrote its ending, and continued the story of life within the two Jia households. One of these was Honglou meng ying (1877), by female poet, Gu Taiqing. Despite its status as the earliest extant novel written by a woman, few studies have been devoted to examining it. Building on research that Ellen Widmer has provided on Gu Taiqing and her work, including Honglou meng ying, I will explore the novel further in terms of its relationship to the parent work and to other sequels written by men, and also examine it on its own terms as a literary work. Some of the main questions that I will address include: how does it compare to other sequels to Honglou meng? How does Gu Taiqing’s continuation of Honglou meng depart from the parent novel? I have organized my discussion by providing an introduction to Gu Taiqing, whilst providing contextual information about women’s education, their relationship to fiction, and the impact of Honglou meng. Chapter One will deal with the broad issue of sequels in the Chinese context, the popularity of writing sequels during the Ming and Qing dynasties, and conclude with some observations about Honglou meng sequels in particular. The second chapter will deal exclusively with Gu Taiqing’s Honglou meng ying, evaluating it in terms of how the author continues the parent work, how she refashions its characters and themes, and how her sequel reflects her own unique concerns (which may not have been part of the original parent work). Finally, I will conclude with some remarks about Honglou meng ying in terms of its relation to sequel writing in late imperial China and its contribution to our understanding of women’s reading and writing in the final years of the Qing dynasty.Arts, Faculty ofAsian Studies, Department ofGraduat

    Studi empirici della traduzione basati sui corpora

    No full text
    Il volume presenta una raccolta di studi recenti condotti nell'ampio e variegato campo interdisciplinare dei corpus translation studies. Il primo capitolo offre una visione dell'evoluzione dei corpus translation studies. Il secondo capitolo esamina le differenze e similarità fra i generi testuali traduttivi e quelli originali, usando la lingua cinese come esempio. Il terzo capitolo presenta uno studio pedagogico focalizzato sul ruolo del translanguaging nella didattica delle lingue moderne. Il quarto capitolo esplora come il messaggio originale, lo stile linguistico e le strategie comunicative del documentario d'indagine di Chai Jing sull'inquinamento atmosferico, Under the Dome, sia stato recepito dal pubblico anglofono inglese attraverso la traduzione e la sua diffusione tramite i media digitali

    On Meng Sen's teaching and lecture notes of Ming and Qing history at Peking University during the 1930s

    No full text
    While teaching the histories of the Ming and Qing dynasties, Meng Sen (1869-1937), developed three textbooks in the 1930s: Lecture Notes on the Ming History (.... Mingshi jiangyi), Lecture Notes on the Qing History (.... Qingshi jiangyi), and Lecture Notes on the History of the Founding of the Manchu State (....... Manzhou kaiguo shi jiangyi). In these book titles, the term " history" refers specifically to "standard history."In tracing Meng Sen's original intention in producing these textbooks, all three works suggest the author's desire to write history. He wrote Lecture Notes on the Ming History to prepare a future revision of the History of the Ming (.. Mingshi); similarly he wrote Lecture Notes on the Qing History and Lecture Notes on the History of the Founding of the Manchu State with the intention to revise the Draft History of the Qing (... Qingshi gao). Meng Sen summarized Sima Guang's (..., 1019-86) view of history as " imitating the good and avoiding the bad," which he believed represented the "essential meaning of history." Meng followed Sima Guang's model in compiling the Lecture Notes on the Ming History and Lecture Notes on the Qing History, as shown in their style and format. By comparison, his writing of the Lecture Notes on the History of the Founding of the Manchu State attempted to merge the traditional annals-biographic style with narrative history from the West, or to pour old wine into a new bottle. Meng Sen presented his innovative efforts at Peking University, introducing young scholars to standards for history writing, and doing his utmost to guide and encourage his students; some of whom became noted scholars in the study of Ming and Qing histories.A&HCIARTICLE2119-1545

    Regarding the Dates of Birth and Death of Li Meng-Yang : Ming Period Poet

    No full text
    In this paper, the author has confirmed the dates of birth and death of Li Meng-Yang, a poet of middle period of the Ming dynasty in China. The author has referred his poems and literature as well as letters written between him and his friends, and critically reviewed various views and arguments about his lifetime compiled over the past four hundred years. In conclusion, the author has determined the date of his birth and death as follows according to lunar calendar. Li Meng-Yang was born on the 7th of December, Cheng-Hua 8 (1472), and died 30th of December, Jia-Jing 8 (1529).departmental bulletin pape

    Characteristics of the Cervical Microbiome in Women with Cervical Insufficiency (CI) and its Role in Predicting the Successful Cerclage / Pessary Intervention

    No full text
    Meng, Meng.Thesis Ph.D. Chinese University of Hong Kong 2016.Includes bibliographical references (leaves ).Abstracts also in Chinese.Title from PDF title page (viewed on …)

    Mckenzieana Meng & Xing, 2022, nom. n.

    No full text
    Genus <i>Mckenzieana</i> nom. n. <p> <i>Helaspis</i> McKenzie 1963: 34 (Mandibulata: Hexapoda: Hemiptera: Diaspididae) is preoccupied by <i>Helaspis</i> Imbrie 1959: 400 (Brachiopoda: Strophomenata: Productida: Productellidae).</p> <p> <b>Type species:</b> <i>Helaspis mexicana</i> McKenzie, 1963: 34.</p> <p> <b>Remarks on nomenclatural change.</b> McKenzie (1963) established the armoured scale genus <i>Helaspis</i> with the type species <i>Helaspis mexicana</i> McKenzie 1963. The genus is a valid name in Hemiptera: Coccomorpha: Diaspididae, subfamily Aspidiotinae, tribe Aspidiotini (Normark <i>et al.</i> 2019). The genus includes only the type species, recorded from Mexico.</p> <p> Unfortunately, the name <i>Helaspis</i> McKenzie 1963 is preoccupied by <i>Helaspis</i> Imbrie 1959, a fossil marine brachiopod genus (Brachiopoda: Strophomenata: Productida: family Productellidae) based on the type species <i>Helaspis luma</i> Imbrie 1959. Thus, <i>Helaspis</i> McKenzie 1963 is a junior homonym of <i>Helaspis</i> Imbrie 1959. According to Article 60 of the International Code of Zoological Nomenclature, a new replacement name is proposed for <i>Helaspis</i> McKenzie 1963: <i>Mckenzieana</i> <b>nom. n.</b></p> <p> <b>Etymology.</b> The replacement name for the genus is derived from the name H.L. McKenzie, the author of the armoured scale insect genus <i>Helaspis</i>; gender feminine.</p>Published as part of <i>Meng, Shitao & Xing, Jichun, 2022, Replacement of names for two armoured scale genera (Hemiptera: Coccomorpha Diaspididae) due to homonymy, pp. 299-300 in Zootaxa 5116 (2)</i> on page 299, DOI: 10.11646/zootaxa.5116.2.7, <a href="http://zenodo.org/record/6367391">http://zenodo.org/record/6367391</a&gt
    corecore